Labarai

Maganin CAR-T na BIOOCUS Medical Group Dual CD19/BCMA ya samar da sakamako mai kyau a cikin Myasthenia Gravis mai tsauri: Tafiyar Majinyaci Matashi

Marasa lafiya 'yan ƙasar Ostiraliya sun cimma nasarar amsawa da wuri tare da maganin BIOOCUS Medical Group na Dual CD19/CD20 CAR-T don DLBCL da ya sake dawowa.

Muhimmancin Bibiya da Duba Lafiya akai-akai Bayan Dashen Kwayoyin Halitta
Bibiyar bayan dashen yana da matuƙar muhimmanci ga marasa lafiya da aka dasa ƙwayoyin halittar jini (HSCT). Dubawa akai-akai yana taimakawa wajen gano matsaloli kamar kamuwa da cuta, cututtukan da aka dasa a kan ƙwayoyin halitta (GVHD), da kuma sake dawowa, wanda ke tabbatar da shiga tsakani da wuri da kuma samun sakamako mafi kyau.

Maganin CAR-T Ya Shawo Kan Mummunan Hasashe a Cikin Lymphoma Mai Matakin B
Wani sabon bincike ya nuna cewa maganin CAR-T zai iya inganta hasashen ga marasa lafiya da ke fama da cutar sankarar B-cell mai inganci (HGBL), wani nau'in cutar sankarar B-cell mai girma, har ma a cikin layukan magani na baya, wanda ke ba da sabon bege ga waɗannan shari'o'in masu ƙalubale.

Maganin CAR-T da wuri don Babban Lymphoma na B-cell yana nuna sakamako mai kyau
Wani bincike da aka yi a baya-bayan nan wanda ya kwatanta maganin CAR-T da wuri da kuma na ƙarshe ga marasa lafiya da ke fama da cutar lymphoma ta B-cell ya nuna cewa maganin da aka yi a baya na iya samar da ingantaccen adadin rayuwa da ƙarancin illa, wanda ke tallafawa amfani da shi azaman magani na biyu.

Maganin CAR-T Ya Nuna Tsaro da Inganci Ga Marasa Lafiyar Ciwon Daji Masu Cututtukan Kai-tsaye ko Kumburi
Wani bincike da aka buga kwanan nan a cikin Nazarin Rheumatology na Lancet ya nuna cewa maganin ƙwayoyin CAR-T yana da aminci kuma yana da tasiri wajen magance cutar lymphoma da myeloma da yawa waɗanda suma ke da cututtukan autoimmune ko kumburi, yana ba da shaida mai kyau don amfani da shi a faɗin duniya.

Fahimtar Nasara Kan Nau'ikan Halittar Manya B-DUKA
Cikakken bita a cikin Jini yana nuna ci gaban da aka samu kwanan nan a fahimtar nau'ikan kwayoyin halitta na manyan ƙwayoyin B-cell na cutar sankarar lymphoblastic mai tsanani (B-ALL). Binciken ya binciki bambancin halittu, tasirin asibiti, da kuma mahimmancin maganin daidaitacce wajen inganta sakamakon marasa lafiya.

Binciken Nasara Ya Tabbatar da Tsaro da Inganci na CD19/CD20 Maganin CAR-T don r/r B-NHL
Wani gwaji na mataki na 1 a cibiyoyi da yawa a China ya nuna aminci da ingancin prizlon-cel, wani magani mai amfani da CD19/CD20 CAR-T mai niyya biyu, wanda ke ba da sabuwar fata ga marasa lafiya da ke fama da cutar sankarar B-cell wacce ba Hodgkin lymphoma ba (r/r B-NHL) da ta sake dawowa/ta sake yin illa.

Sabbin Alamomin Halittu Sun Yi Hasashen Sakamakon Maganin CAR-T a Maganin Myeloma da Yawa
Wani bincike da aka buga kwanan nan a cikin Jini yana gano matakan BCMA (sBCMA) mai narkewa da kuma yawan ciwon daji na metabolism (MTV) a matsayin alamun halitta masu yuwuwar hasashen sakamakon maganin CAR-T a cikin marasa lafiya da suka sake dawowa da kuma waɗanda suka yi rashin lafiya da yawa (RRMM), yana share hanyar dabarun magani na musamman.

Maganin CAR-T: Makomar da ke da Alkawari ga Cututtukan T-Cell
Maganin CAR-T, wanda a da yake samun ci gaba a fannin cutar sankarar ƙwayoyin B, yana nuna kyakkyawan sakamako wajen magance cutar sankarar ƙwayoyin T da cutar sankarar ƙwayoyin T (T-ALL). Wannan maganin da ke ci gaba yana fuskantar ƙalubale na musamman amma gwaje-gwajen asibiti na baya-bayan nan suna ba da bege ga sabbin hanyoyin magance cutar sankarar ƙwayoyin T.

Nazarin Nasara An Buga a cikin Jini: Maganin CAR-T na CD7 da aka Ba da Nanobody don Cutar Leukemia Mai Tsanani
Ƙungiyar Likitoci ta Lu Daopei ta cimma wani gagarumin ci gaba wajen magance cutar sankarar jini mai tsanani (AML) ta hanyar binciken da ta yi kan maganin CD7 CAR-T na nanobody, wanda aka buga a cikin wata mujalla mai suna. Jini.

Masu Hana Ciwon Menin: Maganin da ke da Alaƙa da Ciwon Leukemia Mai Tsanani
Ci gaban da aka samu kwanan nan a cikin masu hana cutar Menin yana ba da zaɓuɓɓukan magani masu kyau ga cutar sankarar myeloid mai tsanani (AML), yana mai da hankali kan maye gurbi na kwayoyin halitta da kuma samar da sabon bege ga shari'o'in da ke da ƙalubale.
